EFIB returns to Brussels. From 27 to 29 October the European Forum for Industrial Biotechnology and the Biobased Economy (EFIB) returns to Europe’s capital, where it was first launched 7 years ago, taking place at the Square, Brussels meeting center. Since then, the event has grown tenfold in size but remains true to its goal of providing the premier meeting place for business and policy throughout the biobased value chain.
EuropaBio and Smithers Rapra, in association with IAR, unveil the highly-anticipated agenda for the European Forum for Industrial Biotechnology (EFIB) from 1-2 October 2014 taking place in Reims, the heart of Champagne-Ardenne (France). Committed to creating a forum to address opportunities and challenges for the biobased economy, EFIB is consistent in attracting an unrivalled calibre of speakers from across the fields of both policy and business. This year’s high level plenary includes a French ministerial address from this year’s host nation, complemented by the European Commission’s take on the future of the European biobased economy. Followed by a discussion on shale gas and how it is impacting investments and market development in petrochemical and biobased value chains, featuring representatives from Shell and European Bioplastics.
Si chiude l’edizione 2013 di Efib, il forum europeo sul biotech industriale e la bioeconomia che quest’anno ha avuto Bruxelles come citta’ ospitante. Si chiude con all’attivo un incremento delle presenze, ma soprattutto con un metasettore che chiede a gran voce una spinta sull’acceleratore della competitivita’ da parte dell’Unione europea.
Everything is ready in Brussels to host EFIB, the European Forum for Industrial Biotechnology and Bio-based economy organized by EuropaBio, the European Association for Bioindustries, and Smithers Rapra which will take place from September 30 to October 2, during the European Biotech Week (from September 30 to October 4), when events across Europe will celebrate biotechnology, an innovative and vibrant sector launched by the 1953 discovery of the DNA molecule, sixty years ago.
“We believe that EFIB (European Forum for Industrial Biotechnology and Bio-based Economy, editor’s note), taking place during the first European Biotech Week, contributes to increase the awareness of Europeans to the bioeconomy.” To say it is Nathalie Moll, Secretary General of EuropaBio, The European Association for Bioindustries, one of the organizers, with Smithers Rapra, of the event which will be held in Brussels from 30 September to 2 October. In this interview with Il Bioeconomista, Moll talks about EFIB – “a single platform for European business leaders, innovators and policymakers to meet, discuss and shape the future of the bioeconomy” – and the latest development of European Bioeconomy, focusing on the Public Private Partnership for Biobased industries (Bridge), “a multisector initiative whose vision is that of a society and economy which increasingly makes everyday products, such as food, feed, textiles, chemicals and fuels, from locally sourced biomass and wastes, rather than from fossil fuels.”
Leading companies and policy makers are collaborating to fuel the growth of the bioeconomy in Europe. The partnership of Biobased and Renewable Industries for Development and Growth in Europe (BRIDGE) is industries vision for building stronger more sustainable value chains, based on renewable raw materials, across Europe. It is the result extensive dialogue between a broad range of sectors, SMEs, Research Institutes and policy makers and, if adopted, will form part of the EU’s new Research and Innovation programme, Horizon 2020. Continue reading →